Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy

Emanuelle Bellaguarda, Kian Keyashian, Joel Pekow, David T. Rubin, Russell D. Cohen, Atsushi Sakuraba*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint Dive into the research topics of 'Prevalence of Antibodies Against JC Virus in Patients With Refractory Crohn's Disease and Effects of Natalizumab Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences